Overview

A Dose-response Study With Strontium Malonate in Postmenopausal Women

Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to compare dose-response effect of three dose levels of strontium malonate to placebo on bone resorption quantified by S-CTX-1 following 12 weeks of treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Osteologix